JENIFER BRANSON: Open Payments
NPI 1235312299 · MELISSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 22 payments from 13 companies in 2025. Trend: 2023 $572 · 2024 $542 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $54 |
| Dexcom, Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Antares Pharma, Inc. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| ABBVIE INC. | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, REXULTI, XYOSTED, VOQUEZNA, MOUNJARO, XIFAXAN, QULIPTA.
Industry payments across TX — which companies pay providers there.
